Your browser doesn't support javascript.
loading
Brain Volume: An Important Determinant of Functional Outcome After Acute Ischemic Stroke.
Schirmer, Markus D; Donahue, Kathleen L; Nardin, Marco J; Dalca, Adrian V; Giese, Anne-Katrin; Etherton, Mark R; Mocking, Steven J T; McIntosh, Elissa C; Cole, John W; Holmegaard, Lukas; Jood, Katarina; Jimenez-Conde, Jordi; Kittner, Steven J; Lemmens, Robin; Meschia, James F; Rosand, Jonathan; Roquer, Jaume; Rundek, Tatjana; Sacco, Ralph L; Schmidt, Reinhold; Sharma, Pankaj; Slowik, Agnieszka; Stanne, Tara M; Vagal, Achala; Wasselius, Johan; Woo, Daniel; Bevan, Stephen; Heitsch, Laura; Phuah, Chia-Ling; Strbian, Daniel; Tatlisumak, Turgut; Levi, Christopher R; Attia, John; McArdle, Patrick F; Worrall, Bradford B; Wu, Ona; Jern, Christina; Lindgren, Arne; Maguire, Jane; Thijs, Vincent; Rost, Natalia S.
Afiliação
  • Schirmer MD; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Boston; Department of Population Health Sciences, German Center for Neurode
  • Donahue KL; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston.
  • Nardin MJ; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston.
  • Dalca AV; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Boston; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown.
  • Giese AK; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston.
  • Etherton MR; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston.
  • Mocking SJT; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown.
  • McIntosh EC; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown.
  • Cole JW; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD; Veterans Affairs Maryland Health Care System, Baltimore, MD.
  • Holmegaard L; Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Jood K; Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Jimenez-Conde J; Department of Neurology, Neurovascular Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Kittner SJ; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD; Veterans Affairs Maryland Health Care System, Baltimore, MD.
  • Lemmens R; Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, KU Leuven-University of Leuven, Flemish Institute for Biotechnology, Vesalius Research Center, Laboratory of Neurobiology, and Department of Neurology, University Hospitals Leuven, Leuven,
  • Meschia JF; Department of Neurology, Mayo Clinic, Jacksonville, FL.
  • Rosand J; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston; Center for Genomic Medicine, Massachusetts General Hospital, Boston; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Ho
  • Roquer J; Department of Neurology, Neurovascular Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Rundek T; Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL.
  • Sacco RL; Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL.
  • Schmidt R; Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz, Austria.
  • Sharma P; Institute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, UK, and St Peter's and Ashford Hospitals Foundation Trust, Chertsey, UK.
  • Slowik A; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Stanne TM; Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Vagal A; Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Wasselius J; Department of Clinical Sciences, Radiology, Lund University, Lund, Sweden; Department of Radiology, Division of Neuroradiology, Skåne University Hospital, Malmö, Sweden.
  • Woo D; Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Bevan S; School of Life Sciences, University of Lincoln, Lincoln, UK.
  • Heitsch L; Division of Emergency Medicine, Washington University School of Medicine, St Louis, MO.
  • Phuah CL; Department of Neurology, Washington University School of Medicine, St Louis, MO; Barnes-Jewish Hospital, St Louis, MO.
  • Strbian D; Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
  • Tatlisumak T; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Levi CR; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Department of Neurology, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Attia J; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • McArdle PF; Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Worrall BB; Department of Neurology and Department of Public Health Sciences, University of Virginia, Charlottesville, VA.
  • Wu O; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown.
  • Jern C; Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Lindgren A; Department of Neurology, Lund University, Lund, Sweden; Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.
  • Maguire J; University of Technology Sydney, Sydney, Australia.
  • Thijs V; Stroke Division, Florey Institute of Neuroscience and Mental Health and Department of Neurology, Austin Health, Heidelberg, Australia.
  • Rost NS; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts General Hospital, Boston.
Mayo Clin Proc ; 95(5): 955-965, 2020 05.
Article em En | MEDLINE | ID: mdl-32370856
OBJECTIVE: To determine whether brain volume is associated with functional outcome after acute ischemic stroke (AIS). PATIENTS AND METHODS: This study was conducted between July 1, 2014, and March 16, 2019. We analyzed cross-sectional data of the multisite, international hospital-based MRI-Genetics Interface Exploration study with clinical brain magnetic resonance imaging obtained on admission for index stroke and functional outcome assessment. Poststroke outcome was determined using the modified Rankin Scale score (0-6; 0 = asymptomatic; 6 = death) recorded between 60 and 190 days after stroke. Demographic characteristics and other clinical variables including acute stroke severity (measured as National Institutes of Health Stroke Scale score), vascular risk factors, and etiologic stroke subtypes (Causative Classification of Stroke system) were recorded during index admission. RESULTS: Utilizing the data from 912 patients with AIS (mean ± SD age, 65.3±14.5 years; male, 532 [58.3%]; history of smoking, 519 [56.9%]; hypertension, 595 [65.2%]) in a generalized linear model, brain volume (per 155.1 cm3) was associated with age (ß -0.3 [per 14.4 years]), male sex (ß 1.0), and prior stroke (ß -0.2). In the multivariable outcome model, brain volume was an independent predictor of modified Rankin Scale score (ß -0.233), with reduced odds of worse long-term functional outcomes (odds ratio, 0.8; 95% CI, 0.7-0.9) in those with larger brain volumes. CONCLUSION: Larger brain volume quantified on clinical magnetic resonance imaging of patients with AIS at the time of stroke purports a protective mechanism. The role of brain volume as a prognostic, protective biomarker has the potential to forge new areas of research and advance current knowledge of the mechanisms of poststroke recovery.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Imageamento por Ressonância Magnética / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mayo Clin Proc Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Imageamento por Ressonância Magnética / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mayo Clin Proc Ano de publicação: 2020 Tipo de documento: Article